Tenet Healthcare (THC) closed down 1.99%

From Nasdaq: 2024-12-30 18:15:21

In the latest trading session, Tenet Healthcare (THC) closed at $125.42, down 1.99% from the previous day, underperforming the S&P 500, Dow, and Nasdaq. Over the past month, THC shares lost 10.31%, worse than the Medical sector and S&P 500. Analysts project a 9.33% EPS increase and a 4.03% revenue decrease in the upcoming earnings report.

Tenet Healthcare’s annual estimates project an 62.89% earnings increase and a 1.01% revenue increase. Recent analyst estimate changes can signal business trends. The Zacks Rank system, ranging from 1 (Strong Buy) to 5 (Strong Sell), predicts future stock performance. THC currently holds a Zacks Rank of 3 (Hold) with a 0.05% decrease in EPS projection.

THC trades at a Forward P/E ratio of 11.25, below the industry average of 11.31. The PEG ratio of 0.57 compares favorably to the industry’s 0.88. The Medical – Hospital industry ranks in the bottom 34% of all industries, according to Zacks Industry Rank. Utilize Zacks.com for stock metrics and industry insights for better investment decisions.

Zacks Investment Research is naming the top 10 stocks for 2025, with a track record of impressive performance. The Zacks Top 10 Stocks gained over 2,000% since 2012, outperforming the S&P 500. Director of Research Sheraz Mian is set to release the 2025 picks on January 2, after careful analysis of 4,400 companies. Don’t miss out on these potential opportunities.



Read more at Nasdaq: Tenet Healthcare (THC) Dips More Than Broader Market: What You Should Know